Page last updated: 2024-10-30

labetalol and Thrombosis

labetalol has been researched along with Thrombosis in 1 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greer, IA1
Walker, JJ1
Calder, AA1
Forbes, CD1

Other Studies

1 other study available for labetalol and Thrombosis

ArticleYear
Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis.
    Lancet (London, England), 1985, Feb-09, Volume: 1, Issue:8424

    Topics: Aspirin; Drug Synergism; Ethanolamines; Humans; Labetalol; Nicardipine; Nifedipine; Platelet Aggrega

1985